Novel treatment strategies for liver disease due to α1-antitrypsin deficiency.
about
Fluphenazine reduces proteotoxicity in C. elegans and mammalian models of alpha-1-antitrypsin deficiencyAFM Imaging Reveals Topographic Diversity of Wild Type and Z Variant Polymers of Human α1-Proteinase InhibitorA genome-wide RNAi screen identifies potential drug targets in a C. elegans model of α1-antitrypsin deficiency.
P2860
Novel treatment strategies for liver disease due to α1-antitrypsin deficiency.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Novel treatment strategies for liver disease due to α1-antitrypsin deficiency.
@en
type
label
Novel treatment strategies for liver disease due to α1-antitrypsin deficiency.
@en
prefLabel
Novel treatment strategies for liver disease due to α1-antitrypsin deficiency.
@en
P2860
P1476
Novel treatment strategies for liver disease due to α1-antitrypsin deficiency.
@en
P2093
David H Perlmutter
Nicholas Maurice
P2860
P304
P356
10.1111/J.1752-8062.2011.00363.X
P407
P577
2012-01-10T00:00:00Z